<DOC>
	<DOCNO>NCT01964313</DOCNO>
	<brief_summary>To describe role genetic factor relationship interaction environmental factor recurrence cardiac event Chinese patient acute coronary syndrome .</brief_summary>
	<brief_title>Acute Coronary Syndrome Genetic Study</brief_title>
	<detailed_description>- Research cohort : Patients diagnose acute coronary syndrome enrol follow 2 year . - Baseline follow variable include patient ' demographic , medical history , ACS event characteristic , clinical treatment option ( interventional cardiology , drug therapy : antithrombotic therapy , treatment recommend guideline ) follow event information . - Blood Sample collection 4ml vein blood draw . Centrifugation plasma WBC do on-site within 30 minute DNA extraction . Samples store -80℃ freezer subsequent application . - A nested case-controlled study design genetic analysis : 1 . Cases : Patients suffer death , myocardial infarction , stroke coronary revascularization bleed 2-year follow . We expect get 600 case study cohort ; 2 . Controls : among patient without event follow , match control 1:1 ratio select accord date admission ( ± 1 month ) , age ( ± 5 year ) , sex , baseline ACS diagnosis , whether treat PCI , pattern antithrombotic therapy study center . - Genotyping Genotype test use exome DNA chip ( Exome Beadchip ) . Exome Beadchip high-throughput DNA chip design Illumina 's , contain 240,000 SNP exon genome may lead functional change . - Analysis : 1 . To analysis impact genetic characteristic selection treatment strategy ACS patient , interaction baseline clinical variable . 2 . To analysis impact genetic characteristic patient outcome , interaction clinical characteristic management pattern .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Written inform consent provide . Contact Order Form provide . Aged 18 year old . Diagnosis STEMI , NSTEMI UA use follow definition : 1 . Criteria STEMI diagnosis : 1 . History chest pain/discomfort 2 . Persistent STsegment elevation ( &gt; 30 min ) ≥ 0.1 mV 2 contiguous ECG lead presumed new leave bundle branch block ( LBBB ) admission 3 . Elevation cardiac biomarkers ( CKMB , troponins ) : least one value 99th percentile local laboratory upper reference limit . 2 . Criteria NSTEMI diagnosis : 1 . History chest pain/discomfort 2 . Lack persistent STsegment elevation , LBBB intraventricular conduction disturbance 3 . Elevation cardiac biomarkers ( CKMB , troponins ) : least one value 99th percentile local laboratory upper reference limit . 3 . Criteria Unstable Angina diagnosis : 1 . Symptoms angina rest minimal exercise 2 . At least 0.5mm ST deviation least 2 lead 3 . No increase biomarkers necrosis 4 . OR objective evidence ischaemia noninvasive imaging OR significant coronary stenosis determine treat physician angiography standard practice study site . Hospitalized within 48 hour onset symptom . Patients eligible participate follow exclusion criterion present : UA , STEMI NSTEMI precipitate complication surgery , trauma , GI bleed postPCI . UA , STEMI NSTEMI occur patient already hospitalize reason . Presence condition/circumstance opinion investigator could significantly limit complete follow patient ( e.g . tourist , nonnative speaker understand local language , psychiatric disturbance ) . Presence serious/severe comorbidities opinion investigator may limit short term ( i.e . 6 month ) life expectancy . Current participation randomise interventional clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>treatment strategy</keyword>
	<keyword>genetics</keyword>
</DOC>